Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Gross Profit (2016 - 2025)

Nephros (NEPH) has 16 years of Gross Profit data on record, last reported at $2.9 million in Q3 2025.

  • For Q3 2025, Gross Profit rose 35.64% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $11.3 million, up 37.13%, while the annual FY2024 figure was $8.7 million, 3.78% up from the prior year.
  • Gross Profit reached $2.9 million in Q3 2025 per NEPH's latest filing, up from $2.8 million in the prior quarter.
  • Across five years, Gross Profit topped out at $3.2 million in Q1 2025 and bottomed at $762000.0 in Q3 2022.
  • Average Gross Profit over 5 years is $1.9 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Gross Profit: tumbled 43.97% in 2022, then skyrocketed 187.93% in 2023.
  • A 5-year view of Gross Profit shows it stood at $1.4 million in 2021, then grew by 6.95% to $1.5 million in 2022, then soared by 33.93% to $2.0 million in 2023, then increased by 22.46% to $2.5 million in 2024, then grew by 17.78% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $2.9 million in Q3 2025, $2.8 million in Q2 2025, and $3.2 million in Q1 2025.